Lukas F. Mager

2.0k total citations · 1 hit paper
15 papers, 1.5k citations indexed

About

Lukas F. Mager is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lukas F. Mager has authored 15 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Lukas F. Mager's work include Gut microbiota and health (6 papers), IL-33, ST2, and ILC Pathways (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Lukas F. Mager is often cited by papers focused on Gut microbiota and health (6 papers), IL-33, ST2, and ILC Pathways (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Lukas F. Mager collaborates with scholars based in Canada, Germany and Switzerland. Lukas F. Mager's co-authors include Kathy D. McCoy, Nicola Pett, Ryan A. Groves, Seungil Paik, Marco Gallo, John Stagg, Regula Burkhard, Markus B. Geuking, Ian A. Lewis and Kirsty Brown and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Lukas F. Mager

14 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy

2020 910 citations Lukas F. Mager, Regula Burkhard et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lukas F. Mager Canada	9	773	547	513	201	172	15	1.5k
Mingzhu Zhu China	21	565 0.7×	318 0.6×	495 1.0×	124 0.6×	166 1.0×	45	1.5k
Marie Vétizou France	11	720 0.9×	869 1.6×	726 1.4×	73 0.4×	123 0.7×	20	1.6k
Stefanie Derer Germany	23	664 0.9×	365 0.7×	661 1.3×	136 0.7×	60 0.3×	52	1.6k
Md Abdul Wadud Khan United States	4	732 0.9×	346 0.6×	130 0.3×	132 0.7×	125 0.7×	4	1.1k
Toshifumi Ohkusa Japan	23	703 0.9×	501 0.9×	494 1.0×	222 1.1×	124 0.7×	54	1.5k
Hyunji Ryu United States	12	650 0.8×	276 0.5×	369 0.7×	191 1.0×	101 0.6×	15	1.3k
Michail Schizas United States	16	531 0.7×	361 0.7×	623 1.2×	142 0.7×	133 0.8×	17	1.4k
Daiko Wakita Japan	29	609 0.8×	783 1.4×	1.6k 3.1×	329 1.6×	72 0.4×	62	2.5k
Romain Daillère France	13	1.4k 1.8×	1.3k 2.4×	767 1.5×	165 0.8×	297 1.7×	18	2.6k
Mayumi Kawada Japan	16	644 0.8×	653 1.2×	466 0.9×	258 1.3×	56 0.3×	20	1.6k

Countries citing papers authored by Lukas F. Mager

Since Specialization

Citations

This map shows the geographic impact of Lukas F. Mager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas F. Mager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas F. Mager more than expected).

Fields of papers citing papers by Lukas F. Mager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas F. Mager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas F. Mager. The network helps show where Lukas F. Mager may publish in the future.

Co-authorship network of co-authors of Lukas F. Mager

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas F. Mager. A scholar is included among the top collaborators of Lukas F. Mager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas F. Mager. Lukas F. Mager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kim, W. Ray, Kun Cheng, Yogesh Singh, et al.. (2025). Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer. Cancer & Metabolism. 13(1). 21–21. 2 indexed citations

Oliveira, Rômulo Silva de, Angela Shupe, Christina Ohland, et al.. (2025). Bifidobacteria-derived exopolysaccharide promotes anti-tumor immunity. Cell Reports. 44(9). 116223–116223. 1 indexed citations

Defaye, Manon, Mansoor Ahmed, Lukas F. Mager, et al.. (2025). Neuronal ALKAL2 and its ALK receptor contribute to the development of colitis-associated colorectal cancer. Proceedings of the National Academy of Sciences. 122(24). e2500632122–e2500632122.

Mager, Lukas F., et al.. (2024). Interaction of microbiota, mucosal malignancies, and immunotherapy—Mechanistic insights. Mucosal Immunology. 17(3). 402–415. 1 indexed citations

Burkhard, Regula, Kirsty Brown, Kirsten Wilson, et al.. (2023). Intestinal colonization regulates systemic anti-commensal immune sensitivity and hyperreactivity. Frontiers in Immunology. 14. 1030395–1030395. 1 indexed citations

Wang, Weilan, Christina Ohland, Lukas F. Mager, et al.. (2022). Exercise and Prebiotic Fiber Provide Gut Microbiota-Driven Benefit in a Survivor to Germ-Free Mouse Translational Model of Breast Cancer. Cancers. 14(11). 2722–2722. 22 indexed citations

McCoy, Kathy D. & Lukas F. Mager. (2021). Impact of the microbiome on tumor immunity. Current Opinion in Immunology. 69. 39–46. 8 indexed citations

Mager, Lukas F., Regula Burkhard, Nicola Pett, et al.. (2020). Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science. 369(6510). 1481–1489. 910 indexed citations breakdown →

Pastille, Eva, Marie-Hélène Wasmer, Alexandra Adamczyk, et al.. (2019). The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer. Mucosal Immunology. 12(4). 990–1003. 116 indexed citations

10.

Neunkirchner, Alina, Bernhard Kratzer, Ursula Smole, et al.. (2018). Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized mice. EBioMedicine. 31. 66–78. 24 indexed citations

11.

Saurer, Leslie, Silvia Rihs, Lukas F. Mager, et al.. (2017). TREM-1 promotes intestinal tumorigenesis. Scientific Reports. 7(1). 14870–14870. 43 indexed citations

12.

Mager, Lukas F., Marie-Hélène Wasmer, Tilman T. Rau, & Philippe Krebs. (2016). Cytokine-Induced Modulation of Colorectal Cancer. Frontiers in Oncology. 6. 96–96. 178 indexed citations

13.

Mager, Lukas F., Carsten Riether, Christian M. Schürch, et al.. (2015). IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms. Journal of Clinical Investigation. 125(7). 2579–2591. 73 indexed citations

14.

Mertz, Kirsten D., Lukas F. Mager, Marie-Hélène Wasmer, et al.. (2015). The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice. OncoImmunology. 5(1). e1062966–e1062966. 80 indexed citations

15.

Klampfl, Thorsten, Lukas F. Mager, Christine Heinzle, et al.. (2011). Up-regulation of 12(S)-lipoxygenase induces a migratory phenotype in colorectal cancer cells. Experimental Cell Research. 318(6). 768–778. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact